Advanced search
Publication Cover
Expert Review of Hematology Volume 8, 2015 - Issue 4
Submit an article Journal homepage
309
Views
5
CrossRef citations to date
0
Altmetric
Drug Profile

Brentuximab vedotin for the treatment of Hodgkin’s lymphoma

Anh PhamDepartment of Hematology and Hematopoietic Cell Transplantation, City of Hope Cancer Center, 1500 E Duarte Rd, Duarte, CA 91010, USA
&
Robert ChenDepartment of Hematology and Hematopoietic Cell Transplantation, City of Hope Cancer Center, 1500 E Duarte Rd, Duarte, CA 91010, USACorrespondence[email protected]
Pages 403-412 | Published online: 12 May 2015

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Avyakta Kallam & James O. Armitage. (2018) Current and emerging treatment options for a patient with a second relapse of Hodgkin’s lymphoma. Expert Review of Hematology 11:4, pages 293-300.
Read now

Articles from other publishers (4)

Sigal Grisariu, Michael Y. Shapira, Reuven Or & Batia Avni. (2018) Thiotepa, Etoposide, Cyclophosphamide, Cytarabine, and Melphalan (TECAM) Conditioning Regimen for Autologous Stem Cell Transplantation in Lymphoma. Clinical Lymphoma Myeloma and Leukemia 18:4, pages 272-279.
Crossref
Karl-Heinz Altmann, Simon Glauser & Tobias Brütsch. 2017. Chemical Biology of Natural Products. Chemical Biology of Natural Products 555 599 .
Chao Liang, Ligeng Xu, Guosheng Song & Zhuang Liu. (2016) Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy. Chemical Society Reviews 45:22, pages 6250-6269.
Crossref
S.P. Egusquiaguirre, J.L. Pedraz, R.M. Hernández & M. Igartua. 2016. Nanoarchitectonics for Smart Delivery and Drug Targeting. Nanoarchitectonics for Smart Delivery and Drug Targeting 813 869 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.